Home  >  Products  >  TXNDC4 (thioredoxin domain containing 4 (endoplasmic reticulum)) Blocking Peptide (the middle region of protein) (100ug)
TXNDC4 (thioredoxin domain containing 4 (endoplasmic reticulum)) Blocking Peptide (the middle region of protein) (100ug)

TXNDC4 (thioredoxin domain containing 4 (endoplasmic reticulum)) Blocking Peptide (the middle region of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TXNDC4 antibody (Catalogue #: ARP58726_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP58726
Size: 100 ug
Weight: 45kDa
Gene: 23071
Format: Lyophilized powder
Target: TXNDC4 mediates thiol-dependent retention in the early secretory pathway, forming mixed disulfides with substrate proteins through its conserved CRFS motif. TXNDC4 inhibits the calcium channel activity of ITPR1. TXNDC4 may have a role in the control of oxidative protein folding in the endoplasmic reticulum. TXNDC4 is required to retain ERO1L and ERO1LB in the endoplasmic reticulum.
Alternative names: ERP44; KIAA0573
See Full Product Listings >